RR
Highly rated in
12
conditions
Highly rated in
12
conditions
Check Dr. Rodney P. Rocconi's experience treating your condition:
About Dr. Rodney P. Rocconi

Rodney Rocconi is a Gynecologic Oncologist and an Oncologist in Mobile, Alabama. Rocconi has been practicing medicine for over 23 years and is highly rated in 12 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Salpingo-Oophorectomy. He is licensed to treat patients in Alabama. Rocconi is currently accepting new patients.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rodney P. Rocconi it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Rodney P. Rocconi accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Molina Healthcare
  •  UnitedHealthcare
  •  Magnolia Health

Call to see if your plan is accepted.
Locations
1660 Spring Hill Ave, Mobile, AL 36604
Background & Education
Graduate Institution
University Of Alabama School Of Medicine, 2000
Specialties
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in AL
Hospital Affiliations
Mobile Infirmary
USA Childrens & Womens Hospital
USA Health University Hospital
Pascagoula Hospital
Thomas Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
A Phase II Study of Cabozantinib (XL184) Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
The Relationship of Racial Genetic Admixture With Endometrial Cancer Outcomes
View 8 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors